DAWN MILLER: Open Payments
NPI 1396795308 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 7 payments from 6 companies in 2025. Trend: 2023 $1,624 · 2024 $286 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| PFIZER INC. | 1 | $29 |
| Incyte Corporation | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $25 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $21 |
Products named: ENHERTU, SCEMBLIX, IBRANCE, LYNPARZA, JAKAFI, NERLYNX.
Industry payments across VA — which companies pay providers there.
